Nuveen Asset Management, LLC Exagen Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.18 - $7.74 $72,681 - $134,583
-17,388 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$8.97 - $14.08 $108,088 - $169,664
-12,050 Reduced 40.93%
17,388 $169,000
Q3 2021

Nov 12, 2021
SELL
$10.25 - $15.21 $15,805 - $23,453
-1,542 Reduced 4.98%
29,438 $425,000
Q2 2021

Aug 16, 2021
BUY
$12.4 - $17.92 $242,940 - $351,088
19,592 Added 172.04%
30,980 $465,000
Q2 2020

Aug 14, 2020
BUY
$11.0 - $16.7 $125,268 - $190,179
11,388 New
11,388 $141,000

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $64.1M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email